Koshinski Asset Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,454
Closed -$276K 709
2022
Q1
$276K Sell
4,454
-134
-3% -$8.31K 0.02% 496
2021
Q4
$372K Buy
4,588
+103
+2% +$8.36K 0.03% 469
2021
Q3
$426K Buy
4,485
+38
+0.9% +$3.61K 0.04% 417
2021
Q2
$438K Sell
4,447
-138
-3% -$13.6K 0.06% 355
2021
Q1
$383K Sell
4,585
-111
-2% -$9.27K 0.04% 415
2020
Q4
$405K Sell
4,696
-245
-5% -$21.1K 0.05% 368
2020
Q3
$388 Sell
4,941
-47
-0.9% -$4 0.05% 346
2020
Q2
$362K Sell
4,988
-569
-10% -$41.3K 0.06% 346
2020
Q1
$257K Hold
5,557
0.05% 374
2019
Q4
$340K Buy
+5,557
New +$340K 0.06% 386
2019
Q3
Sell
-5,077
Closed -$263K 159
2019
Q2
$263K Buy
5,077
+490
+11% +$25.4K 0.11% 221
2019
Q1
$254 Buy
+4,587
New +$254 0.07% 321
2018
Q4
Sell
-5,343
Closed -$372K 415
2018
Q3
$372K Buy
5,343
+1,420
+36% +$98.9K 0.05% 380
2018
Q2
$224K Sell
3,923
-109
-3% -$6.22K 0.07% 342
2018
Q1
$222K Sell
4,032
-1,100
-21% -$60.6K 0.07% 329
2017
Q4
$288K Sell
5,132
-1,944
-27% -$109K 0.07% 345
2017
Q3
$433K Buy
7,076
+213
+3% +$13K 0.14% 223
2017
Q2
$366K Hold
6,863
0.13% 233
2017
Q1
$331K Buy
6,863
+47
+0.7% +$2.27K 0.13% 226
2016
Q4
$272K Sell
6,816
-386
-5% -$15.4K 0.13% 228
2016
Q3
$349K Buy
+7,202
New +$349K 0.17% 188
2016
Q1
Sell
-4,204
Closed -$301K 224
2015
Q4
$301K Buy
4,204
+188
+5% +$13.5K 0.21% 144
2015
Q3
$363K Sell
4,016
-1,011
-20% -$91.4K 0.23% 138
2015
Q2
$454K Buy
5,027
+25
+0.5% +$2.26K 0.29% 105
2015
Q1
$396K Buy
5,002
+20
+0.4% +$1.58K 0.26% 116
2014
Q4
$313K Buy
+4,982
New +$313K 0.18% 158